Bioequivalence of Ertugliflozin/Metformin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components

A fixed‐dose combination (FDC) of ertugliflozin, a selective sodium‐glucose cotransporter 2 inhibitor, and immediate‐release metformin is approved for the treatment of type 2 diabetes mellitus in the United States and European Union. Four open‐label, randomized, 2‐period, single‐dose, crossover stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawra, Vikas Kumar, Liang, Yali, Wei, Hua, Pelletier, Kathleen, Shi, Haihong, Hickman, Anne, Bass, Almasa, Terra, Steven G., Zhou, Susan, Krishna, Rajesh, Sahasrabudhe, Vaishali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003954/
https://www.ncbi.nlm.nih.gov/pubmed/31207178
http://dx.doi.org/10.1002/cpdd.703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003954/
https://www.ncbi.nlm.nih.gov/pubmed/31207178
http://dx.doi.org/10.1002/cpdd.703

Ejemplares similares